MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Spero Therapeutics, Inc. (SPRO)

Spero Therapeutics, Inc. (SPRO)

||
||
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Return on Equity
-21.609
-
54.87
-27.863
Net Profit Margin
-
-
78.42
-135.649
Debt to Asset Ratio
16.226
10.313
14.362
51.091
Cash Ratio
602.444
1,022.572
454.048
356.187
Quick Ratio
612.055
1,049.59
758.751
383.347
Current Ratio
612.055
1,049.59
758.751
383.347

Time Plot

Show the time plot by selecting a row from the table.